DJIA 16,805.41 127.51 0.76%
NASDAQ 4,483.72 30.92 0.69%
S&P 500 1,964.58 13.76 0.71%
market minute promo

ABIOMED, Inc. (NASDAQ: ABMD)

24.18 0.08 (0.33%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ABMD $24.18 0.33%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $24.14
Previous Close $24.10
Daily Range $24.07 - $24.61
52-Week Range $20.29 - $30.77
Market Cap $978.4M
P/E Ratio 133.89
Dividend (Yield) $0.00 (0.0%)
Volume 145,417
Average Daily Volume 207,673
Current FY EPS $0.11

Sector

Healthcare

Industry

Healthcare Information Services

ABIOMED, Inc. (ABMD) Description

The Company is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients. Website: http://www.abiomed.com/

News & Commentary

Abiomed, Inc.: The Best Medical Device Companies of 2013

Abiomed's Impella heart pumps are carving out an important niche in cardiac cath labs.

Commit To Buy ABIOMED At $20, Earn 12.2% Annualized Using Options

Update: Abiomed Announces Clinical Trial Results For Impella RP

ABIOMED Up on Positive Impella RP Clinical Trial Results - Analyst Blog

ABIOMED Up on Positive Impella RP Clinical Trial Results - Analyst Blog

Clinical Trial Results For Impella RP Right Ventricular Heart Failure Trial "Recover Right" Released

Clinical Trial Results For Impella RP Right Ventricular Heart Failure Trial "Recover Right" Released At TCT 2014

ABIOMED (ABMD) Shares Cross Above 200 DMA

Abiomed Falls, Sees Flat Fiscal Q1 Loss and Miss Estimates - Analyst Blog

Abiomed's (ABMD) CEO Michael Minogue on Q1 2015 Results - Earnings Call Transcript

Q1 2015 Abiomed Inc Earnings Conference Call (Webcast)

ABIOMED Acquires Germany's Medical Device Maker - Analyst Blog

Wall Street Comfortable With Covidien Buy; Some See Move By Johnson & Johnson

See More ABMD News...

ABMD's Top Competitors

ABMD $24.18 (0.33%)
Current stock: ABMD
$0.00 (0.00%)
Current stock:
BAX $69.83 (1.06%)
Current stock: BAX
COV $89.64 (1.35%)
Current stock: COV